ABOS- Acumen Pharmaceuticals, Inc.

Name: Acumen Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Acumen Pharmaceuticals, Inc. (ABOS) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. ABOS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Oconnell Daniel Joseph	893.3K	$2.11M	-
CFO	Zuga Matt	309.1K	$729.4K	-
Other	Siemers Eric	258.6K	$610.3K	-
Pres	Doherty James J.	220.9K	$521.3K	-
Other	Meisner Derek M	174.0K	$410.6K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 17, 2026	Porter Derrell	Director	Sale+OE	32,300	$2.33	$75,239.50	-21.3%	-	-
Mar 6, 2026	Meisner Derek M65	Chief Legal Officer &Corp Sec	Sale+OE	2,090	$3.26	$6,813.40	-1.2%	-30.8%	-
Feb 27, 2026	Meisner Derek M65	Chief Legal Officer &Corp Sec	Sale+OE	9,406	$3.01	$28,311.12	-5.1%	-19.1%	-
Jan 28, 2026	Meisner Derek M65	Chief Legal Officer &Corp Sec	Sale+OE	17,756	$3.00	$53,279.82	-4.9%	-12.5%	-
Jan 12, 2026	Oconnell Daniel Joseph53	Chief Executive Officer	Sell	26,472	$1.77	$46,953.87	-1.4%	+43.6%	-
Jan 12, 2026	Meisner Derek M65	Chief Legal Officer &Corp Sec	Sell	50,659	$1.80	$91,073.23	-11.2%	+43.6%	-
Jan 8, 2026	Zuga Matt51	CFO &Chief Business Officer	Sell	6,888	$1.82	$12,512.74	-3.2%	+38.7%	-
Jan 8, 2026	Barton Russell51	Chief Operating Officer	Sell	3,530	$1.86	$6,561.56	-2.8%	+38.7%	-
Jan 8, 2026	Doherty James J.	President And Cdo	Sell	8,167	$1.85	$15,148.08	-6.7%	+38.7%	-
Jan 7, 2026	Schacterle Amy	Chief Regulatory Officer	Sell	1,097	$1.98	$2,176.23	-12.5%	+32.2%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC